| Kathryne R Fox, LPN | |
|
2157 Greenbrier St, Charleston, WV 25311-9623 | |
| (304) 344-5924 | |
| Not Available |
| Full Name | Kathryne R Fox |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 2157 Greenbrier St, Charleston, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669112553 | NPI | - | NPPES |
| 06261989 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 30573 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathryne R Fox, LPN 2157 Greenbrier St, Charleston, WV 25311-9623 Ph: (304) 344-5924 | Kathryne R Fox, LPN 2157 Greenbrier St, Charleston, WV 25311-9623 Ph: (304) 344-5924 |
News Archive
Intarcia Therapeutics, Inc. today announced the presentation of results from its first two phase 3 clinical trials (FREEDOM-1 and FREEDOM-1 HBL) of its late-stage investigational candidate ITCA 650 (exenatide delivered continuously via a small matchstick-size subcutaneous osmotic mini-pump just once or twice yearly) at the 75th Scientific Sessions of the American Diabetes Association.
Suicide rates in those aged 10-19 in the UK declined by 28% in the seven year period from 1997-2003, shows a study published today in The Journal of Child Psychology and Psychiatry. The study, carried out by researchers at the University of Manchester, showed that the decline was particularly marked in young males, where rates declined by 35%.
Women with cardiovascular conditions should be cared for during pregnancy by a cardio-obstetrics team or health care providers experienced in high-risk pregnancies to provide specialized maternity care for the mother and fetus, according to a new American Heart Association scientific statement, Cardiovascular Considerations in Caring for Pregnant Patients, published today in the Association's flagship journal Circulation.
IntegenX, Inc. today at the 60th Annual American Society of Human Genetics Meeting announced the launch of their Apollo 324 System, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation sequencing.
Sepracor Inc. announced today the preliminary results of a large-scale, 671-patient Phase III study of OMNARIS® (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescent patients. In this study, OMNARIS HFA met its primary efficacy endpoint by demonstrating a statistically significant reduction versus placebo in the reflective total nasal symptom score averaged over a two-week treatment period.
› Verified 2 days ago
Michelle Dawn Comer, LPN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2157 Greenbrier St, Charleston, WV 25311 Phone: 304-344-5924 |